Study comparing people with Charcot-Marie-Tooth and healthy controls
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without it. It aims to better understand CMT, using both clinical symptoms and genetic test results, which may help future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or the person) have a clinical diagnosis of Charcot-Marie-Tooth disease (CMT).
- You have genetic test results confirming CMT.
- If you join as a healthy control, you do not have CMT or CMT-related nerve symptoms.
- You must be willing to participate and not refuse consent.
- You cannot join if your nerve problem is caused by something else (like injury/trauma, immune disease, or toxin exposure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without nerve disease. The goal is to better understand different CMT types and how symptoms and nerve test results change over time.
This study examines tremor (involuntary shaking) in people with Charcot-Marie-Tooth disease, a genetic nerve condition that affects the legs and feet. Researchers will compare people with CMT who have tremor to healthy volunteers to better understand this symptom.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This study collects blood, saliva, or skin samples from people with Charcot-Marie-Tooth disease (CMT) and healthy volunteers. The samples are used to create stem cells (iPSCs) and build a biobank to help researchers understand and treat CMT.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
Hear when a new Charcot-Marie-Tooth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.